I-Tech is a Gothenburg based company with global reach, holding all IP and regulatory rights to its all new antifouling agent Selektope (generic name, Medetomidine). Relying on academic research in Gothenburg, I-Tech has since 2006 successfully transformed the scientific invention into a commercially ready and available antifouling agent.
I-Tech has had several listings as top start-up company and is now an entirely commercially driven company with continuous revenue.
The company’s vision is to become the preferred supplier to the professional and non-professional antifouling market. The company’s mission is to bring new dimensions to the global antifouling industry. streams.
ITech AB holds all IP and regulatory rights to the game-changing core biocide Selektope and they also control the largest and most efficient source of medetomidine production.